New Peptide Drug for the Treatment of Alzheimer's Disease (No. 0230)

New Peptide Drug for the Treatment of Alzheimer's Disease (No. 0230)
2022/09/27 | Created on 2022/09/26
<< Back to all technologies Summary Alzheimer's disease (AD) is estimated to affe...
アルツハイマー病治療のための新しいペプチド医薬品（No. 0230）
2022/09/27 | Created on 2022/09/26
<< 技術一覧に戻る概要アルツハイマー型認知症（AD）は、�...
Introducing Technology Transfer Consultation with the EVP
2022/09/20
Weekly Open Office Hours with Gil Granot-Mayer, Executive Vice President of Technology Development and Innovation, Starting September 22, 2022 The&nb...
2022 ADR
2022/09/29 | Created on 2021/04/02
October 03-07 2022 Registration Deadline: 25th September, 2022 Neurons are a diverse class of cells, characterized...
Peptide drugs for enhancing opioid analgesia and reducing tolerance development (No. 0221)
2022/09/12
<< Back to all technologies Summary Opioids are essential in clinical pain manag...
[2022年9月] TDICイノベーション・ニュースレターを配信
2022/09/12
OISTで技術移転や産学連携を担う技術開発イノベーションセンター（TDIC）では、ニュースレターを配信していま�...
オピオイドの鎮痛作用増強と耐性獲得抑制のためのペプチド医薬品 (No. 0221)
2023/01/03 | Created on 2022/09/12
<< 技術一覧に戻る概要オピオイドは臨床における疼痛管理...
Sep 2022: Latest TDIC Innovation Newsletter has just been posted
2022/09/12
[September 2022] The latest TDIC Innovation Newsletter has just been posted! The Technology Development & Innovation Center (TDIC) i...
2022年アクセラレーター・プログラムチームの紹介
2022/09/12
2022年9月7日　意識と身体にアプローチ健康問題の解決に挑む起業家たち 2022年度のI2スタートアップ・アクセラ...
New Entrepreneurial Teams Join OIST Startup Accelerator Program
2022/09/12
OKINAWA, JAPAN, Wednesday, 7 September --Startups connect mind and body to impact disease treatment Read our news story about 2 entrepreneuri...